These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies. Fenwick C; Croxatto A; Coste AT; Pojer F; André C; Pellaton C; Farina A; Campos J; Hacker D; Lau K; Bosch BJ; Gonseth Nussle S; Bochud M; D'Acremont V; Trono D; Greub G; Pantaleo G J Virol; 2021 Jan; 95(3):. PubMed ID: 33144321 [TBL] [Abstract][Full Text] [Related]
8. Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective. Li D; Li J J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33318065 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests. Klausberger M; Duerkop M; Haslacher H; Wozniak-Knopp G; Cserjan-Puschmann M; Perkmann T; Lingg N; Aguilar PP; Laurent E; De Vos J; Hofner M; Holzer B; Stadler M; Manhart G; Vierlinger K; Egger M; Milchram L; Gludovacz E; Marx N; Köppl C; Tauer C; Beck J; Maresch D; Grünwald-Gruber C; Strobl F; Satzer P; Stadlmayr G; Vavra U; Huber J; Wahrmann M; Eskandary F; Breyer MK; Sieghart D; Quehenberger P; Leitner G; Strassl R; Egger AE; Irsara C; Griesmacher A; Hoermann G; Weiss G; Bellmann-Weiler R; Loeffler-Ragg J; Borth N; Strasser R; Jungbauer A; Hahn R; Mairhofer J; Hartmann B; Binder NB; Striedner G; Mach L; Weinhäusel A; Dieplinger B; Grebien F; Gerner W; Binder CJ; Grabherr R EBioMedicine; 2021 May; 67():103348. PubMed ID: 33906067 [TBL] [Abstract][Full Text] [Related]
10. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms. Turbett SE; Anahtar M; Dighe AS; Garcia Beltran W; Miller T; Scott H; Durbin SM; Bharadwaj M; Thomas J; Gogakos TS; Astudillo M; Lennerz J; Rosenberg ES; Branda JA J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33020186 [TBL] [Abstract][Full Text] [Related]
12. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033 [TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain. Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647 [TBL] [Abstract][Full Text] [Related]
15. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay. Mariën J; Ceulemans A; Michiels J; Heyndrickx L; Kerkhof K; Foque N; Widdowson MA; Mortgat L; Duysburgh E; Desombere I; Jansens H; Van Esbroeck M; Ariën KK J Virol Methods; 2021 Feb; 288():114025. PubMed ID: 33227340 [TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins. Zhang P; Gao Q; Wang T; Ke Y; Mo F; Jia R; Liu W; Liu L; Zheng S; Liu Y; Li L; Wang Y; Xu L; Hao K; Min W; Liu X; Yang R; Li S; Lin C; Zhao Y Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):921-928. PubMed ID: 33184753 [TBL] [Abstract][Full Text] [Related]
17. Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens. Dobaño C; Vidal M; Santano R; Jiménez A; Chi J; Barrios D; Ruiz-Olalla G; Rodrigo Melero N; Carolis C; Parras D; Serra P; Martínez de Aguirre P; Carmona-Torre F; Reina G; Santamaria P; Mayor A; García-Basteiro AL; Izquierdo L; Aguilar R; Moncunill G J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33127841 [TBL] [Abstract][Full Text] [Related]
18. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan. Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990 [TBL] [Abstract][Full Text] [Related]
19. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays. Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306 [TBL] [Abstract][Full Text] [Related]
20. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]